Meta-analysis finds intranasal esketamine boosts remission in MDD and TRD fast, but side effects and short trials leave long-term questions.
Ayse K. Coskun, MD
Advertisement
Dr Coskun is a second-year psychiatry resident at Creighton University.
Articles by Ayse K. Coskun, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Positive Topline Results From Phase 3 Emerge Study of DT120 ODT in Major Depressive Disorder
2
FDA Issues CRL for Cytisinicline for Smoking Cessation in Adults
3
Psychiatric Pharmacogenomics: An Overview
4
Phase 2 Analysis of ML-004 for Autism Spectrum Disorder Fails to Meet Endpoint
5